These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32956692)

  • 1. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
    Chen Y; Fu Z; Li D; Yue Y; Liu X
    Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimizations of an ELISA-like high-throughput screening assay for the discovery of β-catenin/TCF4 interaction antagonists].
    Fu Z; Yan G; Zhu X; Liu X; Chen Y
    Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2878-2889. PubMed ID: 34472305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of an ELISA-based high throughput screening method for novel anticancer agents targeting β-catenin/Lef1 interaction].
    Chen Y; Niu X; Li Y; Liu X
    Sheng Wu Gong Cheng Xue Bao; 2019 Apr; 35(4):707-717. PubMed ID: 31001956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the interaction of BCL9 with beta-catenin and development of fluorescence polarization and surface plasmon resonance binding assays for this interaction.
    Kawamoto SA; Thompson AD; Coleska A; Nikolovska-Coleska Z; Yi H; Wang S
    Biochemistry; 2009 Oct; 48(40):9534-41. PubMed ID: 19715304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel fluorescence polarization-based assay for studying the β-catenin/Tcf4 interaction.
    Tian W; Xu Y; Han X; Duggineni S; Han X; Huang Z; An J
    J Biomol Screen; 2012 Apr; 17(4):530-4. PubMed ID: 22127421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1.
    Kim GH; Fang XQ; Lim WJ; Park J; Kang TB; Kim JH; Lim JH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The osteogenic differentiation of human adipose-derived stem cells is regulated through the let-7i-3p/LEF1/β-catenin axis under cyclic strain.
    Luo Y; Ge R; Wu H; Ding X; Song H; Ji H; Li M; Ma Y; Li S; Wang C; Du H
    Stem Cell Res Ther; 2019 Nov; 10(1):339. PubMed ID: 31753039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AlphaScreen selectivity assay for β-catenin/B-cell lymphoma 9 inhibitors.
    Zhang M; Wisniewski JA; Ji H
    Anal Biochem; 2015 Jan; 469():43-53. PubMed ID: 25312469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
    Gehrke I; Gandhirajan RK; Kreuzer KA
    Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
    Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
    Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARsylated transcription factor EB (TFEB) regulates the expression of a subset of Wnt target genes by forming a complex with β-catenin-TCF/LEF1.
    Kim S; Song G; Lee T; Kim M; Kim J; Kwon H; Kim J; Jeong W; Lee U; Na C; Kang S; Kim W; Seong JK; Jho EH
    Cell Death Differ; 2021 Sep; 28(9):2555-2570. PubMed ID: 33753903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTUD7B Activates Wnt Signaling Pathway through the Interaction with LEF1.
    Lee Y; Piao HL; Kim J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Gandhirajan RK; Staib PA; Minke K; Gehrke I; Plickert G; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
    Neoplasia; 2010 Apr; 12(4):326-35. PubMed ID: 20360943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening.
    Yamaguchi K; Nagatoishi S; Tsumoto K; Furukawa Y
    Cancer Sci; 2020 Mar; 111(3):783-794. PubMed ID: 31912579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
    Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway.
    Zhou AD; Diao LT; Xu H; Xiao ZD; Li JH; Zhou H; Qu LH
    Oncogene; 2012 Jun; 31(24):2968-78. PubMed ID: 22020335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells.
    Tian H; Lv P; Ma K; Zhou C; Gao X
    Biochem Biophys Res Commun; 2010 Jul; 398(3):519-24. PubMed ID: 20599763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
    Kahler RA; Westendorf JJ
    J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.